{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:23:14Z","timestamp":1783520594565,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21S11906200"],"award-info":[{"award-number":["21S11906200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["201409002900"],"award-info":[{"award-number":["201409002900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771306"],"award-info":[{"award-number":["81771306"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFF0702401"],"award-info":[{"award-number":["2021YFF0702401"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies","award":["2023-DK-01"],"award-info":[{"award-number":["2023-DK-01"]}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["24ZR1449500"],"award-info":[{"award-number":["24ZR1449500"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08267-y","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:34:02Z","timestamp":1778751242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KLRG1 silencing increases the efficacy of CAR NK cell therapy against colon cancer via SHP-2\/ZAP-70\/NF-\u03baB signal pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Yiran","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asad","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Ajmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4999-4168","authenticated-orcid":false,"given":"Wenzheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"8267_CR1","doi-asserted-by":"crossref","unstructured":"Fuchs N, Zhang L, Calvo-Barreiro L, Kuncewicz K, Gabr M. Inhibitors of immune checkpoints: small molecule- and peptide-based approaches. J Pers Med. 2024:14.","DOI":"10.3390\/jpm14010068"},{"key":"8267_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2217\/imt-2020-0181","volume":"12","author":"N El-Khazragy","year":"2020","unstructured":"El-Khazragy N, Ghozy S, Emad P, Mourad M, Razza D, Farouk YK, Mohamed NA, Ahmed MK, Youssef T, Bahnasawy YM, Elmasery S. Chimeric antigen receptor T cells immunotherapy: challenges and opportunities in hematological malignancies. Immunotherapy. 2020;12:1341\u201357.","journal-title":"Immunotherapy"},{"key":"8267_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa1709919","volume":"378","author":"JH Park","year":"2018","unstructured":"Park JH, Rivi\u00e8re I, Gonen M, Wang X, S\u00e9n\u00e9chal B, Curran KJ, Sauter C, Wang Y, Santomasso B, Mead E, et al. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia. N Engl J Med. 2018;378:449\u201359.","journal-title":"N Engl J Med"},{"key":"8267_CR4","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","volume":"377","author":"SS Neelapu","year":"2017","unstructured":"Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, Braunschweig I, Oluwole OO, Siddiqi T, Lin Y, et al. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma. N Engl J Med. 2017;377:2531\u201344.","journal-title":"N Engl J Med"},{"key":"8267_CR5","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1158\/1078-0432.CCR-17-3196","volume":"24","author":"AT Bj\u00f6rklund","year":"2018","unstructured":"Bj\u00f6rklund AT, Carlsten M, Sohlberg E, Liu LL, Clancy T, Karimi M, Cooley S, Miller JS, Klimkowska M, Schaffer M, et al. Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML. Clin Cancer Res. 2018;24:1834\u201344.","journal-title":"Clin Cancer Res"},{"key":"8267_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","volume":"23","author":"NK Wolf","year":"2023","unstructured":"Wolf NK, Kissiov DU, Raulet DH. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat Rev Immunol. 2023;23:90\u2013105.","journal-title":"Nat Rev Immunol"},{"key":"8267_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","volume":"22","author":"KM Maalej","year":"2023","unstructured":"Maalej KM, Merhi M, Inchakalody VP, Mestiri S, Alam M, Maccalli C, Cherif H, Uddin S, Steinhoff M, Marincola FM, Dermime S. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer. 2023;22:20.","journal-title":"Mol Cancer"},{"key":"8267_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12964-024-01714-7","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen S, Tang X, Peng Y, Jiang T, Zhang X, Li J, Liu Y, Yang Z. The role of KLRG1: a novel biomarker and new therapeutic target. Cell Communication Signal. 2024;22:337.","journal-title":"Cell Communication Signal"},{"key":"8267_CR9","doi-asserted-by":"crossref","unstructured":"Chan IS, Kn\u00fatsd\u00f3ttir H, Ramakrishnan G, Padmanaban V, Warrier M, Ramirez JC, Dunworth M, Zhang H, Jaffee EM, Bader JS, Ewald AJ. Cancer cells educate natural killer cells to a metastasis-promoting cell state. J Cell Biol. 2020:219.","DOI":"10.1083\/jcb.202001134"},{"key":"8267_CR10","doi-asserted-by":"crossref","unstructured":"Goel N, Needham M, Soler-Ferran D, Cotreau MM, Escobar J, Greenberg S. POS1342 depletion of KLRG1+ T cells in a first-in-human clinical trial of ABC008 in inclusion body myositis (IBM). Ann Rheum Dis. 2022;81:1008\u20131009.","DOI":"10.1136\/annrheumdis-2022-eular.2141"},{"key":"8267_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1084\/jem.20051986","volume":"203","author":"M Ito","year":"2006","unstructured":"Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med. 2006;203:289\u201395.","journal-title":"J Exp Med"},{"key":"8267_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/1479-5876-11-262","volume":"11","author":"Y-P Peng","year":"2013","unstructured":"Peng Y-P, Zhu Y, Zhang J-J, Xu Z-K, Qian Z-Y, Dai C-C, Jiang K-R, Wu J-L, Gao W-T, Li Q, et al. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. J Translational Med. 2013;11:262.","journal-title":"J Translational Med"},{"key":"8267_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.humimm.2016.05.022","volume":"77","author":"H Hou","year":"2016","unstructured":"Hou H, Mao L, Wang J, Liu W, Lu Y, Yu J, Zhou Y, Mao L, Wang F, Sun Z. Establishing the reference intervals of NK cell functions in healthy adults. Hum Immunol. 2016;77:637\u201342.","journal-title":"Hum Immunol"},{"key":"8267_CR14","doi-asserted-by":"publisher","first-page":"eadr9395","DOI":"10.1126\/sciadv.adr9395","volume":"11","author":"X Hui","year":"2025","unstructured":"Hui X, Xue M, Ren Y, Chen Y, Chen X, Farooq MA, Ji Y, Zhan W, Huang Y, Du B, et al. GPR132 regulates the function of NK cells through the G\u03b1s\/CSK\/ZAP70\/NF-\u03baB signaling pathway as a potential immune checkpoint. Sci Adv. 2025;11:eadr9395.","journal-title":"Sci Adv"},{"key":"8267_CR15","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.15252\/embj.201592757","volume":"34","author":"GT Chen","year":"2015","unstructured":"Chen GT, Waterman ML. Cancer: leaping the E-cadherin hurdle. EMBO J. 2015;34:2307\u20139.","journal-title":"EMBO J"},{"key":"8267_CR16","doi-asserted-by":"publisher","first-page":"1369406","DOI":"10.3389\/fimmu.2024.1369406","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yao J, Ajmal I, Farooq MA, Jiang W. shRNA-mediated gene silencing of HDAC11 empowers CAR-T cells against prostate cancer. Front Immunol. 2024;15:1369406.","journal-title":"Front Immunol"},{"key":"8267_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40425-019-0553-9","volume":"7","author":"T Courau","year":"2019","unstructured":"Courau T, Bonnereau J, Chicoteau J, Bottois H, Remark R, Assante Miranda L, Toubert A, Blery M, Aparicio T, Allez M, Le Bourhis L. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA\/B and NKG2A targeting for cancer treatment. J Immunother Cancer. 2019;7:74.","journal-title":"J Immunother Cancer"},{"key":"8267_CR18","first-page":"80","volume":"24","author":"VG Subrakova","year":"2020","unstructured":"Subrakova VG, Kulemzin SV, Belovezhets TN, Chikaev AN, Chikaev NA, Koval OA, Gorchakov AA, Taranin AV. shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells. Vavilovskii Zhurnal Genet Selektsii. 2020;24:80\u20136.","journal-title":"Vavilovskii Zhurnal Genet Selektsii"},{"key":"8267_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00262-025-04059-3","volume":"74","author":"C Xu","year":"2025","unstructured":"Xu C, Cao K, Ma A, Zheng M, Xu Y, Tang L. KLRG1 expression induces functional exhaustion of NK cells in colorectal cancer patients. Cancer Immunol Immunother. 2025;74:203.","journal-title":"Cancer Immunol Immunother"},{"key":"8267_CR20","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.4049\/jimmunol.178.8.4764","volume":"178","author":"ND Huntington","year":"2007","unstructured":"Huntington ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, Degli-Esposti MA, Smyth MJ, Tarlinton DM, Nutt SL. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol. 2007;178:4764\u201370.","journal-title":"J Immunol"},{"key":"8267_CR21","doi-asserted-by":"publisher","first-page":"811091","DOI":"10.3389\/fimmu.2021.811091","volume":"12","author":"WJ Cao","year":"2021","unstructured":"Cao WJ, Zhang XC, Wan LY, Li QY, Mu XY, Guo AL, Zhou MJ, Shen LL, Zhang C, Fan X, et al. Immune Dysfunctions of CD56(neg) NK Cells Are Associated With HIV-1 Disease Progression. Front Immunol. 2021;12:811091.","journal-title":"Front Immunol"},{"key":"8267_CR22","doi-asserted-by":"publisher","first-page":"11626","DOI":"10.1128\/JVI.01515-13","volume":"87","author":"M Wang Jia","year":"2013","unstructured":"Wang Jia M, Cheng Yong Q, Shi L, Ying Ruo S, Wu Xiao Y, Li Guang Y, Moorman Jonathan P, Yao Zhi Q. KLRG1 Negatively Regulates Natural Killer Cell Functions through the Akt Pathway in Individuals with Chronic Hepatitis C Virus Infection. J Virol. 2013;87:11626\u201336.","journal-title":"J Virol"},{"key":"8267_CR23","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1084\/jem.20132459","volume":"211","author":"G Min-Oo","year":"2014","unstructured":"Min-Oo G, Bezman NA, Madera S, Sun JC, Lanier LL. Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection. J Exp Med. 2014;211:1289\u201396.","journal-title":"J Exp Med"},{"key":"8267_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/intimm\/dxm004","volume":"19","author":"MS Tessmer","year":"2007","unstructured":"Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G, Brossay L. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int Immunol. 2007;19:391\u2013400.","journal-title":"Int Immunol"},{"key":"8267_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/jimmun\/vkaf012","volume":"214","author":"AJ Millan","year":"2025","unstructured":"Millan AJ, Allain V, Nayak I, Libang JB, Quijada-Madrid LM, Arakawa-Hoyt JS, Ureno G, Rothrock AG, Shemesh A, Aguilar OA, et al. SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy. J Immunol. 2025;214:384\u201398.","journal-title":"J Immunol"},{"key":"8267_CR26","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1084\/jem.20060650","volume":"203","author":"S Dong","year":"2006","unstructured":"Dong S, Corre Ba, Foulon E, Dufour E, Veillette A, Acuto O, Fdr M. T cell receptor for antigen induces linker for activation of T cell\u2013dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2. J Exp Med. 2006;203:2509\u201318.","journal-title":"J Exp Med"},{"key":"8267_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1182\/blood.V126.23.283.283","volume":"126","author":"K Bardhan","year":"2015","unstructured":"Bardhan K, Patsoukis N, Sari D, Anagnostou T, Chatterjee P, Freeman GJ, Li L, Boussiotis VA. PD-1 Inhibits TCR Proximal Signaling By Sequestering SHP-2 Phosphatase and Facilitating Csk-Mediated Inhibitory Phosphorylation of Lck. Blood. 2015;126:283\u2013283.","journal-title":"Blood"},{"key":"8267_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41375-020-0809-x","volume":"35","author":"T Hideshima","year":"2021","unstructured":"Hideshima T, Ogiya D, Liu J, Harada T, Kurata K, Bae J, Massefski W, Anderson KC. Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways. Leukemia. 2021;35:177\u201388.","journal-title":"Leukemia"},{"key":"8267_CR29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S1097-2765(01)00369-0","volume":"8","author":"W Lu","year":"2001","unstructured":"Lu W, Gong D, Bar-Sagi D, Cole PA. Site-Specific Incorporation of a Phosphotyrosine Mimetic Reveals a Role for Tyrosine Phosphorylation of SHP-2 in Cell Signaling. Mol Cell. 2001;8:759\u201369.","journal-title":"Mol Cell"},{"key":"8267_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13578-023-01005-7","volume":"13","author":"D Guo","year":"2023","unstructured":"Guo D, Jin C, Gao Y, Lin H, Zhang L, Zhou Y, Yao J, Duan Y, Ren Y, Hui X, et al. GPR116 receptor regulates the antitumor function of NK cells via G\u03b1q\/HIF1\u03b1\/NF-\u03baB signaling pathway as a potential immune checkpoint. Cell Bioscience. 2023;13:51.","journal-title":"Cell Bioscience"},{"key":"8267_CR31","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.4049\/jimmunol.166.9.5654","volume":"166","author":"TM Herndon","year":"2001","unstructured":"Herndon TM, Shan XC, Tsokos GC, Wange RL. ZAP-70 and SLP-76 regulate protein kinase C-theta and NF-kappa B activation in response to engagement of CD3 and CD28. J Immunol. 2001;166:5654\u201364.","journal-title":"J Immunol"},{"key":"8267_CR32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","volume":"21","author":"L Peng","year":"2024","unstructured":"Peng L, Sferruzza G, Yang L, Zhou L, Chen S. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. Cell Mol Immunol. 2024;21:1089\u2013108.","journal-title":"Cell Mol Immunol"},{"key":"8267_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.smim.2014.02.007","volume":"26","author":"N Shifrin","year":"2014","unstructured":"Shifrin N, Raulet DH, Ardolino M. NK cell self tolerance, responsiveness and missing self recognition. Semin Immunol. 2014;26:138\u201344.","journal-title":"Semin Immunol"},{"key":"8267_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Nassif Kerbauy L, Overman B, Thall P, Kaplan M, et al. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors. N Engl J Med. 2020;382:545\u201353.","journal-title":"N Engl J Med"},{"key":"8267_CR35","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","volume":"10","author":"O Melaiu","year":"2019","unstructured":"Melaiu O, Lucarini V, Cifaldi L, Fruci D. Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors. Front Immunol. 2019;10:3038.","journal-title":"Front Immunol"},{"key":"8267_CR36","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4049\/jimmunol.168.6.2585","volume":"168","author":"SH Robbins","year":"2002","unstructured":"Robbins SH, Nguyen KB, Takahashi N, Mikayama T, Biron CA, Brossay L. Cutting Edge: Inhibitory Functions of the Killer Cell Lectin-Like Receptor G1 Molecule During the Activation of Mouse NK Cells1. J Immunol. 2002;168:2585\u20139.","journal-title":"J Immunol"},{"key":"8267_CR37","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.18632\/oncotarget.26659","volume":"10","author":"SA Greenberg","year":"2019","unstructured":"Greenberg SA, Kong SW, Thompson E, Gulla SV. Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models. Oncotarget. 2019;10:1399\u2013406.","journal-title":"Oncotarget"},{"key":"8267_CR38","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1200\/JCO-24-02081","volume":"43","author":"S Ouladan","year":"2025","unstructured":"Ouladan S, Orouji E. Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy. J Clin Oncol. 2025;43:994\u20131005.","journal-title":"J Clin Oncol"},{"key":"8267_CR39","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s10620-012-2552-2","volume":"58","author":"D Jie","year":"2013","unstructured":"Jie D, Zhongmin Z, Guoqing L, Sheng L, Yi Z, Jing W, Liang Z. Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer. Dig Dis Sci. 2013;58:1581\u20139.","journal-title":"Dig Dis Sci"},{"key":"8267_CR40","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.4049\/jimmunol.1600590","volume":"197","author":"B M\u00fcller-Durovic","year":"2016","unstructured":"M\u00fcller-Durovic B, Lanna A, Polaco Covre L, Mills RS, Henson SM, Akbar AN. Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5\u2032-Monophosphate\u2013Activated Protein Kinase. J Immunol. 2016;197:2891\u20139.","journal-title":"J Immunol"},{"key":"8267_CR41","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00262-011-1050-2","volume":"60","author":"B Sanchez-Correa","year":"2011","unstructured":"Sanchez-Correa B, Morgado S, Gayoso I, Bergua JM, Casado JG, Arcos MJ, Bengochea ML, Duran E, Solana R, Tarazona R. Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands. Cancer Immunol Immunother. 2011;60:1195\u2013205.","journal-title":"Cancer Immunol Immunother"},{"key":"8267_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT, Cromer MK, Vakulskas CA, Collingwood MA, Zhang L, Bode NM, et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat Med. 2019;25:249\u201354.","journal-title":"Nat Med"},{"key":"8267_CR43","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","volume":"24","author":"RJ Ihry","year":"2018","unstructured":"Ihry RJ, Worringer KA, Salick MR, Frias E, Ho D, Theriault K, Kommineni S, Chen J, Sondey M, Ye C, et al. p53 inhibits CRISPR\u2013Cas9 engineering in human pluripotent stem cells. Nat Med. 2018;24:939\u201346.","journal-title":"Nat Med"},{"key":"8267_CR44","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1172\/JCI99317","volume":"128","author":"J Hsu","year":"2018","unstructured":"Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault MC, Trevino TN, Azimi CS, Scheer AK, Randolph HE, Thompson TW, et al. Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade. J Clin Invest. 2018;128:4654\u201368.","journal-title":"J Clin Invest"},{"key":"8267_CR45","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fimmu.2017.00760","volume":"8","author":"J Bi","year":"2017","unstructured":"Bi J, Tian Z. NK Cell Exhaustion. Front Immunol. 2017;8:760.","journal-title":"Front Immunol"},{"key":"8267_CR46","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3389\/fimmu.2016.00413","volume":"7","author":"YS Rocca","year":"2016","unstructured":"Rocca YS, Roberti MP, Juli\u00e1 EP, Pampena MB, Bruno L, Rivero S, Huertas E, S\u00e1nchez Loria F, Pairola A, Caignard A, et al. Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15. Front Immunol. 2016;7:413.","journal-title":"Front Immunol"},{"key":"8267_CR47","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","volume":"95","author":"DH Kaplan","year":"1998","unstructured":"Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A. 1998;95:7556\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8267_CR48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nri911","volume":"2","author":"JA Trapani","year":"2002","unstructured":"Trapani JA, Smyth MJ. Functional significance of the perforin\/granzyme cell death pathway. Nat Rev Immunol. 2002;2:735\u201347.","journal-title":"Nat Rev Immunol"},{"key":"8267_CR49","doi-asserted-by":"crossref","unstructured":"Litak J, Mazurek M, Grochowski C, Kamieniak P, Roli\u0144ski J. PD-L1\/PD-1 axis in glioblastoma multiforme. Int J Mol Sci. 2019:20.","DOI":"10.3390\/ijms20215347"},{"key":"8267_CR50","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","volume":"209","author":"T Yokosuka","year":"2012","unstructured":"Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, Hashimoto-Tane A, Azuma M, Saito T. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med. 2012;209:1201\u201317.","journal-title":"J Exp Med"},{"key":"8267_CR51","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.4049\/jimmunol.166.9.5654","volume":"166","author":"TM Herndon","year":"2001","unstructured":"Herndon TM, Shan XC, Tsokos GC, Wange RL. ZAP-70 and SLP-76 Regulate Protein Kinase C-\u03b8 and NF-\u03baB Activation in Response to Engagement of CD3 and CD28. J Immunol. 2001;166:5654\u201364.","journal-title":"J Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08267-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08267-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:02:19Z","timestamp":1783519339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08267-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8267"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08267-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving humans were approved by University Committee on Human Research Protection under approval number 2023-03-061-H02-K00. The studies were conducted in accordance with the local legislation and institutional requirements. The animal study was approved by the Institutional Animal Care and Use Committee of East China Normal University, approval number m20210611. The study was conducted in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declared that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"868"}}